Last 6 months revenue from sales fell 59% to just $87,000.
Pretty sure they've been falling every quarter for
awhile. There's been no approval by regulators in the USA.
The only jurisdiction with actual insurance reimbursement for the device is the UK and that hasn't increased usage in the UK.
The last cr we had resulted in a 100% dilution and a 50% reduction in the market cap.
There is definitely still positive signs with new trials and possibly Germany approving payment .
But they just don't seem to be able to sell the device to more than a handful of people each year.
Last 6 months revenue from sales fell 59% to just $87,000.Pretty...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $35.79M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $57.81K | 6.814M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2730736 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 10051301 | 11 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |